Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma

Recent studies demonstrate an increased risk of second primary malignancies (SPM) in multiple myeloma (MM) patients on maintenance lenalidomide following autologous stem cell transplantation (ASCT). There may be other risk factors driving SPM post-ASCT in MM, so we explored this possibility through...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Krishnan, Amrita Y., Mei, Matthew, Sun, Can-Lan, Thomas, Sandra H., Berano Teh, Jennifer, Kang, Tongjun, Htut, Myo, Somlo, George, Sahebi, Firoozeh, Forman, Stephen J., Bhatia, Smita
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553262/
https://ncbi.nlm.nih.gov/pubmed/23073267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.09.023
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak